• Proteoform-Specific Drug Interactions in Native Membranes

  2026-05-03

  This paper pioneers the direct analysis of proteoform-specific drug interactions within native cell membrane environments using advanced native top-down mass spectrometry. By revealing how post-translational modifications and alternative splicing shape ligand binding, the study reshapes our understanding of pharmacological selectivity and off-target effects, especially for PDE5 inhibitors like Vardenafil.

• BicD and MAP7 Synergistically Activate Drosophila Kinesin-1

  2026-05-02

  This study elucidates how the adaptor protein BicD and microtubule-associated protein MAP7 activate homodimeric Drosophila kinesin-1 through distinct yet complementary mechanisms. The findings advance understanding of intracellular transport regulation and offer mechanistic insights valuable for molecular motor research.

• MLN8237 (Alisertib): Molecular Mechanisms and Assay Innovati

  2026-05-01

  Explore the advanced molecular mechanisms of MLN8237 (Alisertib) as a selective Aurora A kinase inhibitor. This article uniquely connects mechanistic insights with assay design and practical cancer biology applications, offering depth beyond existing protocol or workflow guides.

• 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole: Protocols & P

  2026-05-01

  Leverage 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) for precise transcriptional elongation inhibition and advanced cell fate manipulation. This guide translates cutting-edge research into actionable steps, troubleshooting, and performance optimization for transcriptional, antiviral, and stem cell workflows.

• AGEs Impair Macrophage Autophagy and S. aureus Clearance via

  2026-04-30

  This study uncovers how advanced glycation end products (AGEs), prevalent in diabetes, inhibit autophagosome-lysosome fusion in macrophages by upregulating ARL8, reducing the ability to clear intracellular Staphylococcus aureus. The findings highlight a mechanistic link between diabetes-related metabolic changes and impaired innate immunity, with implications for autophagy and lysosomal function research.

• Hexa-acylated LPS Enhances Anti-PD-1 Cancer Immunotherapy vi

  2026-04-30

  This study identifies hexa-acylated lipopolysaccharides (LPS) from specific gut microbiota as functional enhancers of immune checkpoint inhibitor (ICI) efficacy in cancer. By dissecting LPS structural diversity and its impact on TLR4 signaling, the findings illuminate new predictors and modulators for immunotherapy response.

• BCKAs Aerobically Activate HIF1α Signaling in Vascular Cells

  2026-04-29

  This study uncovers that branched chain α-ketoacids (BCKAs) can trigger HIF1α signaling in human vascular cells under normoxic conditions. These findings illuminate a novel metabolic signaling axis relevant to pulmonary vascular biology and disease, with direct implications for modeling angiogenesis and vascular remodeling in research.

• HyperFluor™ 488 Goat Anti-Mouse IgG: Precision for Endotheli

  2026-04-29

  Discover how HyperFluor 488 Goat Anti-Mouse IgG enables advanced endothelial injury research, with unique insight into its role in quantitative vascular assays. This article reveals technical strategies for superior fluorescent detection and workflow optimization.

• Decoding S-Phase Dynamics: EdU Imaging Kits in Translational

  2026-04-28

  This thought-leadership article unpacks the mechanistic, workflow, and translational advantages of EdU Imaging Kits (488) for cell proliferation analysis. Integrating recent advances and a landmark study on HAUS1-driven hepatocellular carcinoma, it offers actionable guidance for researchers seeking to optimize S-phase measurement and bridge basic discovery with clinical impact.

• Senescence Phenotypes in Prostate Cancer: Insights from Enza

  2026-04-28

  This study systematically dissects how different prostate cancer therapies—DNA damage inducers and Enzalutamide—elicit distinct senescence phenotypes with divergent responses to senolytic agents. The findings highlight the mechanistic diversity of therapy-induced senescence and underscore the need for context-specific strategies in targeting senescent cancer cells.

• SB743921: Applied Workflows for Potent Kinesin Spindle Prote

  2026-04-27

  SB743921 is a benchmark tool for inducing precise mitotic arrest and apoptosis in diverse cancer models, enabling robust in vitro and in vivo workflows. This article delivers stepwise protocols, advanced troubleshooting, and evidence-driven tips to maximize SB743921's impact in cancer research.

• Necrostatin 2: Optimizing Necroptosis Inhibition Workflows

  2026-04-27

  Necrostatin 2 (Nec-2) enables precise, reproducible inhibition of necroptosis via potent RIPK2 targeting, making it indispensable for dissecting programmed necrotic cell death in disease models. This article details experimental workflows, troubleshooting strategies, and actionable insights—bridging recent membrane biology breakthroughs with practical lab execution.

• Evaluating Mianserin HCl: Clinical Efficacy, Side Effects, a

  2026-04-26

  This article analyzes the foundational clinical trial comparing Mianserin Hydrochloride to amitriptyline, focusing on efficacy, safety, and pharmacokinetic monitoring. The study provides robust evidence for Mianserin HCl as an effective 5-HT2 receptor antagonist in antidepressant research, with implications for future translational and protocol-based studies.

• 2'3'-cGAMP (sodium salt): Reliable Activation of cGAS-STING

  2026-04-25

  This article delivers a scenario-driven, evidence-backed analysis of how 2'3'-cGAMP (sodium salt) (SKU B8362) addresses common laboratory challenges in cell viability, proliferation, and STING pathway assays. Drawing on peer-reviewed literature and validated product data, we examine best practices for reproducibility, sensitivity, and vendor selection, positioning SKU B8362 as a robust tool for innate immunity and immunotherapy research.

• Human Gastrin I Peptide: Precision Tool for Gastric Acid Pat

  2026-04-24

  Human Gastrin I peptide unlocks unprecedented precision in modeling gastric acid secretion and CCK2 receptor signaling, especially within advanced hiPSC-derived organoid systems. This guide delivers actionable protocols, troubleshooting insights, and a bridge from cutting-edge organoid research to translational gastrointestinal disease modeling.

14766 records 1/985 page Next 12345 下5页 Last page